Treating dentin hypersensitivity: therapeutic choices made by dentists of the northwest PRECEDENT network.
BACKGROUND
Methods used by dental practitioners to diagnose and treat dentin hypersensitivity are not well documented. The authors conducted a survey of dentists in the Northwest Practice-based REsearch Collaborative in Evidence-based DENTistry (PRECEDENT) to ascertain the treatment methods they used. Methods. Via an Internet survey, the authors collected data regarding methods used for diagnosis and treatment of dentin hypersensitivity from 209 Northwest PRECEDENT dentists.


RESULTS
The PRECEDENT dentists indicated that they most often used fluoride varnishes and gels, advice regarding toothbrushing and diet, bonding agents, restorative materials and glutaraldehyde/2-hydroxyethyl methacrylate (HEMA) to treat dentin hypersensitivity. They reported that the most successful treatments were fluorides, glutaraldehyde/HEMA, bonding agents, potassium nitrates and restorative treatments; they considered observation, advice regarding toothbrushing and diet and laser therapy to be the least successful. Dentists listed fluorides, calcium phosphates, glutaraldehyde/HEMA and bonding agents as the treatments most desirable for inclusion in a future randomized clinical trial of dental hypersensitivity treatments.


CONCLUSIONS
Dentists rely on patients to assess the severity of dentin hypersensitivity. Modalities for the diagnosis and treatment of hypersensitivity are diverse. Methods used to diagnose and treat dentin hypersensitivity in practice are challenging to justify.


CONCLUSIONS
Practitioners should be aware of the diversity of methods available for diagnosing and treating dentin hypersensitivity as they manage the care of their patients with this condition.
Cunha-Cruz
Joana
J
Department of Dental Public Health Sciences, School of Dentistry, University of Washington, 1959 NE Pacific St., Box 357475, Seattle, Wash. 98195-7475, USA. silvajcc@u.washington.edu
Wataha
John C
JC
Zhou
Lingmei
L
Manning
Walter
W
Trantow
Michael
M
Bettendorf
Meishan M
MM
Heaton
Lisa J
LJ
Berg
Joel
J
D000328:Adult; D002130:Calcium Phosphates / Q000627:therapeutic use; D003625:Data Collection; D003738:Dental Cements / Q000627:therapeutic use; D018865:Dental Research / Q000458:organization & administration*; D003793:Dental Restoration, Permanent; D057133:Dentin Desensitizing Agents / Q000627:therapeutic use*; D003807:Dentin Sensitivity / Q000175:diagnosis* / Q000628:therapy; D005260:Female; D005460:Fluorides, Topical / Q000627:therapeutic use; D005976:Glutaral / Q000627:therapeutic use; D006801:Humans; D007256:Information Systems; D008297:Male; D008875:Middle Aged; D015205:Northwestern United States; D011795:Surveys and Questionnaires; D055815:Young Adult
D002130:Calcium Phosphates; D003738:Dental Cements; D057133:Dentin Desensitizing Agents; D005460:Fluorides, Topical; D005976:Glutaral
J Ir Dent Assoc. 1997;43(1):7-9
9584750
J Oral Rehabil. 2002 Mar;29(3):219-25
11896837
J Clin Periodontol. 2002 Nov;29(11):997-1003
12472992
Br Dent J. 1999 Dec 11;187(11):606-11; discussion 603
16163281
J Clin Periodontol. 1983 Jul;10(4):341-50
6309917
J Clin Periodontol. 1997 Nov;24(11):808-13
9402502
J Clin Periodontol. 1996 Nov;23(11):989-92
8951625
J Am Dent Assoc. 2008 Mar;139(3):339-45
18310739
Br Dent J. 1984 Jul 7;157(1):16-9
6588978
J Oral Rehabil. 2001 Jan;28(1):20-5
11298905
J Am Dent Assoc. 2010 Jul;141(7):889-99
20592411
J Oral Rehabil. 1999 Sep;26(9):710-4
10520145
J Can Dent Assoc. 2003 Apr;69(4):221-6
12662460
J Oral Rehabil. 1997 Sep;24(9):666-72
9357747
J Oral Rehabil. 1997 Jan;24(1):15-9
9049914
Br Dent J. 1987 Apr 11;162(7):253-6
3472555
Int Dent J. 1972 Jun;22(2):219-27
4505631
Endod Dent Traumatol. 1995 Oct;11(5):240-4
8625939